Elagolix: How far can it go in the world of gynecology?

Rachel B. Danis

doi:10.1016/j.xfre.2023.04.002

Elagolix: How far can it go in the world of gynecology?

Rachel B. Danis

In: F&S Reports · 2023 · vol. 4(2) , pp. 163–164 · doi:10.1016/j.xfre.2023.04.002 · PMID:37398614 · W4364380987

editorial OA: gold CC0

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reviews the potential applications and limitations of elagolix, a GnRH antagonist, for managing gynecological conditions like endometriosis and uterine fibroids.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (7)

Does timing matter when initiating elagolix in a natural menstrual cycle? via openalex
The role of elagolix in the suppression of ovulation in donor oocyte cycles via openalex
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
W2610244466 via openalex
W1963761453 via openalex
W6796314619 via openalex
W6801138792 via openalex

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-04T00:00:01.174412+00:00

License: CC0 · commercial use OK

[1] Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist 2017

[2] The role of elagolix in the suppression of ovulation in donor oocyte cycles 2023

[3] Does timing matter when initiating elagolix in a natural menstrual cycle? 2021